000			01907 a2200481 4500
005			20250515110521.0
264		0	_c20080515
008			200805s 0 0 eng d
022			_a1464-3391
024	7		_a10.1016/j.bmc.2008.01.047 _2doi
040			_aNLM _beng _cNLM
100	1		_aReddy, M V Ramana
245	0	0	_aDesign, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors. _h[electronic resource]
260			_bBioorganic & medicinal chemistry _cApr 2008
300			_a3907-16 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aBinding Sites
650	0	4	_aBlood Platelets _xdrug effects
650	0	4	_aCyclooxygenase 2 _xchemistry
650	0	4	_aCyclooxygenase 2 Inhibitors _xchemical synthesis
650	0	4	_aDrug Design
650	0	4	_aFluorine Compounds _xchemical synthesis
650	0	4	_aHumans
650	0	4	_aHydrogen Bonding
650	0	4	_aIndoles _xchemistry
650	0	4	_aLipoxygenase Inhibitors _xchemical synthesis
650	0	4	_aMagnetic Resonance Spectroscopy
650	0	4	_aMethylation
650	0	4	_aModels, Molecular
650	0	4	_aMolecular Structure
650	0	4	_aPyrazoles _xchemical synthesis
650	0	4	_aStereoisomerism
650	0	4	_aStructure-Activity Relationship
650	0	4	_aSulfur Compounds _xchemical synthesis
700	1		_aBilla, Vinay K
700	1		_aPallela, Venkat R
700	1		_aMallireddigari, Muralidhar R
700	1		_aBoominathan, Rengasamy
700	1		_aGabriel, Jerome L
700	1		_aReddy, E Premkumar
773	0		_tBioorganic & medicinal chemistry _gvol. 16 _gno. 7 _gp. 3907-16
856	4	0	_uhttps://doi.org/10.1016/j.bmc.2008.01.047 _zAvailable from publisher's website
999			_c17777270 _d17777270